Top related persons:
Top related locs:
Top related orgs:

Search resuls for: "Rebecca Torrence"


25 mentions found


Best Buy has been digging into healthcare since 2018, focusing on virtual care and home health. The electronics retailer bought Current Health in 2021 for $400 million as part of that push. It's another example of Best Buy continuing to invest in its healthcare business despite falling retail sales. Best Buy, McGhee said, wants to support patients across the entire continuum of care without actually providing that medical care. "Best Buy is there as an enabler, the plumbing that allows care at home to happen."
Persons: Christopher McGhee, McGhee, hasn't, Matt Bilunas, It's Organizations: Health
Weight-loss startup Calibrate has struggled to get patients access to buzzy drugs like Ozempic. Kenyon's startup Calibrate, which she launched in June 2020, is one of the healthcare companies feeding the frenzy. CalibrateThe company is now running up against several massive challenges: Weight-loss drugs are expensive and in short supply, and health insurers are increasingly reluctant to pay for them. Kenyon said about 20% of Calibrate members do not have coverage for weight-loss medications, and around half of those people request refunds from Calibrate. Want to tell us about your experience with Calibrate or weight-loss drugs?
Persons: lightbulb, Isabelle Kenyon, Kenyon, Jenny Craig, OptumRx, She's, she's, Saxenda, , weren't, It's, they've, Holly, hadn't, hasn't, Claire Rosenzweig, Rosenzweig, it's, Andrew Kelly, Shelby Livingston, Rebecca Torrence Organizations: New, Tiger Global, Founders Fund, Optum Ventures, FedEx, Food and Drug Administration, Jefferies, Better Business Bureau, BBB, Better Business, Metropolitan New, Better, Apple, Businessolver, Optum, UnitedHealth, Employees, REUTERS, Madryn Asset Management, SM Ventures, Ventures Locations: America, New York, Danish, GLP, Florida, Metropolitan New York, slivingston@insider.com, rtorrence@insider.com
Sword Health wants to be profitable before an IPO, and it's aiming to hit that milestone in 2024. Virgilio Bento founded Sword Health in 2015 to give patients around the world access to virtual physical therapy. Bento isn't interested in taking Sword public before the company is profitable, he said, a milestone he expects to reach next year. "And I don't want to be a public company that's not profitable because that puts us in a very tricky situation." Sword Health uses wearables to monitor user movement and provide physical therapy virtually.
Persons: Virgilio Bento, Sword, Bento isn't, Bento, hadn't, he's, hasn't Organizations: Health, Sword Health, Smart
Eureka Health is building a platform to help patients with chronic conditions find new treatments. Eureka Health used this 11-slide pitch deck to land $7 million in a round led by Khosla Ventures. Eureka Health seeks to give patients with chronic conditions a community to find new treatments based on reports of what other patients have tried. Then, Eureka patients can log how effective a specific treatment was for their symptoms, as well as any side effects they may have experienced. Eureka Health provided Insider with the deck it used to raise $7 million in seed funding.
Persons: Zain Memon, Noah MacCallum, Memon, MacCallum, Anne Wojcicki, Susan Wojcicki, Eureka, we're Organizations: Eureka Health, Khosla Ventures, Health, South Park, SciFi, Able Partners, Bow, 23andMe, South Locations: Eureka, South Park
Dr. Adrian Jacques Ambrose, 35, wants to make healthcare, especially mental-health care, more accessible. Ambrose is a senior medical director in the Department of Psychiatry at Columbia University Irving Medical Center. Columbia University Irving Medical CenterAmbrose, who goes professionally by Jacques, is driven by how confusing healthcare is. As a senior medical director in the Department of Psychiatry at Columbia University Irving Medical Center, he oversees about 50 physicians and 100 other clinicians across four clinical sites. "How do I continue to inculcate this dream of advocating for not only better healthcare, but better healthcare for vulnerable populations and minority populations?"
Persons: Adrian Jacques Ambrose, Ambrose, Columbia University Irving Medical Center Ambrose, Jacques, , David Satcher, Ambrose doesn't, Rose Organizations: of Psychiatry, Columbia University Irving Medical Center, Leadership Institute Locations: Vietnam, Hawaii
We asked top VCs to name the most promising healthtech startups of 2023. VCs nominated startups in their portfolios and companies with which they had no financial ties. It's tough for digital-health startups to raise money these days. But promising startups can still stand out in this environment, as VCs focus on backing upstarts positioned to win big. To identify the most promising startups in healthtech, Insider asked VCs for their recommendations — including firms they'd invested in, and ones they hadn't.
Persons: VCs, upstarts, they'd, Read Organizations: Venture Locations: healthtech
In the first half of 2023, healthcare investors have written big checks for their top startup picks. 2023 is on track to be the lowest year of healthcare funding since 2019, Rock Health says. Digital-health startups in the US raised $6.1 billion in the first half of 2023, Rock Health's H1 2023 funding report published on Monday found. Right now, 2023 is on track to be the lowest healthcare funding year since 2019, according to Rock Health. Krasniansky said Rock Health expects many of the impending shutdowns to impact healthcare startups that sell products and services to patients online and on-demand, especially direct-to-consumer companies like telemedicine or mail-order-pharmacy startups.
Persons: It's, haven't, Healthcare's, healthcare's, Adriana Krasniansky, Krasniansky, Ian Chiang, he's, Lynne Chou O'Keefe, it's, Corey McCann, Chou O'Keefe, Organizations: Rock Health, megadeals, Monogram Health, Frist Cressey Ventures, Flare Capital Partners, Define Ventures, Pear, Madison, Pear Therapeutics
A Headspace therapist told the LA Times he was laid off one day after a patient came out to him. The patient now has no way of contacting him, the therapist said, because he was booted from Headspace's patient care system immediately after being laid off. "I'm the first person they've ever talked to about it," the therapist told the LA Times. But by handling the layoffs the way it did, Headspace "just really screwed over their entire client base," the therapist told the Times. Thirty-three of those employees were therapists, a company spokesperson told Insider.
Persons: they've, Headspace, They're Organizations: LA Times, Headspace Health, Los Angeles Times, Times
Alfie Health built an algorithm to create personalized treatment plans for obesity. Alfie Health is jumping in the ring with perhaps the only selling point in healthcare right now that's hotter than weight-loss medications — artificial intelligence. Alfie Health runs as a virtual obesity-care clinic to provide video visits with doctors and health coaches, with individual treatment plans developed using ObesityRx. In June, Alfie Health raised $2.1 million in pre-seed funding led by Y Combinator and Nina Capital. Here's the presentation Alfie Health used to raise $2.1 million.
Persons: Alfie Health, Combinator, Alfie Health's, Alexander Singh, Y Combinator, Nina Capital, Alfie, Singh, Wegovy Organizations: Nina, Goodwater, Phoenix Investment Club Locations: GLP
Patient complaints go beyond the Wegovy shortageKaitlyn's complaints echo an array of issues faced by other Ro patients seeking weight-loss drugs. The patients Insider interviewed asked to be identified by their first names to protect their privacy. In this chat log, a Ro weight-loss patient sends messages to the startup asking to cancel the program. Reitano told Insider that around 90% of Ro patients got a response within 24 hours. "Until these DTC companies generally start getting into the muck of healthcare, they're not going to have a material impact," Parker told Insider.
Persons: Ro, Zachariah Reitano, Reitano, Li Ran, Robyn Phelps, Kaitlyn, She'd, didn't, she's, couldn't, Max Kerwick, drugstores, Max, Ro's, aren't, hasn't, Florian Gaertner, it's, TJ Parker, they're, Parker Organizations: New York, Getty, Better Business Bureau, Nordisk, Better Business, CareMetx, Ro, TechCrunch Locations: Xinhua, New York, New York City
Fertility companies are thriving as the rest of the healthcare industry stumbles. Many healthcare companies have seen their growth stunted by the market downturn, but fertility startups are defying the odds. Alessia Pierdomenico/Reuters Big returnsProgyny's success this year is boosting investor sentiment for private fertility companies, F-Prime Capital partner Carl Byers said. And some fertility companies are trying to stand out further by saying they can lower costs for employers. Experts predicted the fertility industry will see further consolidation this year, including more clinic acquisitions by private equity and by some fertility startups.
Persons: Kindbody, Scott Schoenhaus, Sarah James, Cantor Fitzgerald, PitchBook, Progyny, James, Alessia Pierdomenico, Carl Byers, Byers, Asima Ahmad, Carrot, Cantor Fitzgerald's James, Gina Bartasi, Peter Anevski, he's, Anevski, Rebecca Torrence Organizations: Morning, The Business Research Company, Investors, Reuters, Prime, Clinics, Maven, for Disease Control, Fertility
Carta Healthcare raised a $25 million Series B from backers like health system Memorial Hermann. That puts startups in need of a Series B round in a tough position. Insider got an exclusive look at the pitch deck Carta Healthcare used to raise $25 million in Series B funding. This article was initially published in November 2022 and has been updated in June following the official close of Carta's Series B. Here's the 18-slide presentation Carta Healthcare used to raise $25 million in Series B funding.
Persons: Hermann, Matt Hollingsworth, Brigham, Hollingsworth, Anna Brody, Carta, hasn't Organizations: Healthcare, Investors, Rock Health, Carta, Memorial Hermann Health, UnityPoint, Paramark Ventures, Frist Cressey Ventures, American College of Cardiology, Asset Management Ventures, Innovation, Mass, Maverick Ventures Investment Fund, Storm Ventures Locations: , San Francisco
Strive Health just raised $166 million in May from investors like NEA and CVS Health Ventures. See the presentation that got Strive Health a $140 million Series B in March 2021. In May, Strive Health announced it raised $166 million in Series C funding led by healthcare venture firm NEA. The round included CVS Health Ventures, CapitalG, Echo Health Ventures, Town Hall Ventures, Ascension Ventures, and Redpoint. The Series C is Strive Health's latest raise since its $140 million Series B in March 2021.
Persons: Chris Riopelle, Riopelle Organizations: NEA, CVS Health Ventures, Health, Echo Health Ventures, Hall Ventures, Ascension Ventures, CapitalG, Google
With digital therapeutics' trailblazers in jeopardy, experts think more failures are on the horizon. Covering digital therapeutics hasn't been easyInsurers, the ultimate gatekeepers in healthcare, have been slow to warm to the idea of reimbursing prescription digital therapeutics. Plus, most digital therapeutics don't integrate with electronic-health-records systems, making it difficult for clinicians to track their patients' progress. Senators reintroduced a bill in March that would guarantee Medicare reimbursement for prescription digital therapeutics. Want to tell us about your experience with digital therapeutics?
Persons: Pear, It's, Akili, Jeffrey Abraham, Rick Bartels, Bartels, Corey McCann, Matt Stoudt, Stoudt, Matthew Stoudt, keener, we'll, that's, Abraham, Rebecca Torrence Organizations: Morning, Pear Therapeutics, Food and Drug Administration, FDA, Digital Therapeutics, Pear, Centers, Medicare, Services, Senators, CMS
A former Louisiana secretary of health is building a startup to get families primary care at home. Nest Health landed $15 million in seed funding in May from 8VC and Blue Venture Fund. Check out the pitch deck that Nest used to get funds for its expansion in New Orleans and beyond. For four years, Dr. Rebekah Gee served as the secretary of the Louisiana health department. Here's the pitch deck Nest Health used to land $15 million.
Persons: Rebekah Gee, Gee, 8VC, Annie E, she's Organizations: Health, Blue Venture, Blue Venture Fund, Casey Foundation Locations: Louisiana, 8VC, New Orleans, Gee
I'm Diamond Naga Siu, and I'm taking a few days off to watch my best friend graduate with their PhD. (Don't worry, my colleagues in London will be bringing you your daily dose of tech news while I'm away.) Pharmacy startup TruePill is searching for its panacea. Employees told to "drink the Kool-Aid" at Larry Page's startup. Current and former employees told Insider about the recent turmoil.
The startup used this pitch deck to get backing from top healthcare VC firm General Catalyst. The Magoons' new startup, Adonis, raised $5.6 million in seed funding in October to solve that problem with tech. Just under seven months later, Adonis has raised $17.3 million more in Series A funding, led by top healthcare VC firm General Catalyst. "Given all the work we do with health systems, we know how complicated and poorly organized these systems are, despite all the money they're collecting," she said. Check out the pitch deck Adonis used to get $17.3 million led by General Catalyst.
"We were shocked," a former employee in Truepill's business development division said of the layoffs. Insider spoke with five former and two current Truepill employees about the challenges the company is confronting after a tumultuous year. Truepill was hiring employees rapidly, accumulating about 1,800 employees by the spring of 2022, according to one former employee in Truepill's business division. Since then, there's been a companywide push to inch closer to profitability, one of the current employees told Insider. It's also downsizing its Miami pharmacy, the current employee said.
The digital-health sector in 2020 and 2021 was the hottest part of healthcare. We spoke with top bankers and dealmakers to understand what comes next as the market cools. The pace of digital-health deals has generally slowed since the highs of 2021. Founders can thank rising interest rates, a punishing stock market for digital-health companies, and a minor banking crisis to name just a few reasons for that. Here are the healthcare industry's go-to investment bankers, in alphabetical order, and their predictions for which trends may push digital-health deals forward after a funding slump.
Digital health, once the darling of the healthcare industry, is having a tough go of it. After a pandemic-fueled surge when health services and offerings utilizing tech were prioritized, digital health has come back down to earth. The similarities between digital health and fintech are striking. For both fintechs and digital health, this year has served as a reminder that they're only partly tech companies. Click here for predictions from 16 bankers and dealmakers on the future of digital health.
98point6 has stopped providing virtual care and is focusing on licensing its care delivery platform. When 98point6 raised $20 million in September, it had no plans to sell its virtual care business, according to CEO Jay Burrell. Running the virtual care business took a lot more cash, though, and the digital health market was still tumbling. In March, 98point6 sold its virtual care business to Transcarent for $100 million. The fresh capital brings 98point6's total funding to $297 million, excluding the $100 million Transcarent deal, per the company.
Inato, which matches pharma companies with hospitals for clinical trials, just landed $20 million. Three months after raising $14 million in Series A funding in February 2020, Inato's founders realized they were making the wrong product. The Paris-based startup was founded in 2016 to help pharmaceutical companies find the right sites to conduct their clinical trials. Now, pharma companies post their clinical trials onto Inato's platform, and sites can apply for the trials they're interested in. Inato provided Insider with the pitch deck it used to raise $20 million in Series A-2 funding.
Healthcare startups are launching to prescribe weight-loss drugs such as Ozempic. They're chasing what's projected to be a $100 billion market for the drugs. Venture-backed health startups are vying for a piece of the booming market for new prescription drugs designed to help with weight loss. Many startups offering weight-loss drugs have flooded social media platforms with ads for the shots. Insider rounded up 13 venture-backed startups competing for customers in the lucrative GLP-1 weight-loss market, listed from least to most funding raised.
'As startups dive into prescribing hot new weight loss drugs, Hims & Hers is taking a backseat. Its CEO said Hims wants to offer GLP-1s for weight loss, but thinks it's too early. He cited challenges in the young market like insurers refusing to cover GLP-1s and drug shortages. After Hims & Hers' first profitable quarter ever, the startup is thinking about getting in on telehealth's weight-loss craze. An 'inconsistent' supply chainExploding demand for the new weight-loss drugs has also resulted in shortages, which affect all patients prescribed GLP-1s, not just those using the drugs for weight loss.
Healthcare startups are launching to prescribe weight-loss drugs such as Ozempic. They're chasing what's projected to be a $100 billion market for the drugs. Venture-backed health startups are vying for a piece of the booming market for new prescription drugs designed to help with weight loss. Many startups offering weight-loss drugs have flooded social media platforms with ads for the shots. Insider rounded up 13 venture-backed startups competing for customers in the lucrative GLP-1 weight-loss market, listed from least to most funding raised.
Total: 25